Sesamin Protects against APAP-Induced Acute Liver Injury by Inhibiting Oxidative Stress and Inflammatory Response via Deactivation of HMGB1/TLR4/NFκB Signal in Mice

Figure 8

The therapeutic effect of sesamin posttreatment on APAP-induced liver injury in mice: (a) serum ALT activity; (b) serum AST activity; (c) hepatic caspase three activity; (d) hepatic caspase nine activity. Data were expressed as mean ± SD; sesamin group mice were oral gavage with 100 mg/kg sesamin, APAP group mice were intraperitoneally injected with 350 mg/kg APAP for 24 hr, sesamin + APAP group mice received oral gavages of sesamin 100 mg/kg at 16.5, 8.5, and 0.5 hr for three times before 350 mg/kg APAP administration (biological repeats n = 6), , , compared with APAP group.

(a)

(b)

(c)

(d)